Abstract
PET/CT has made significant inroads into routine oncological practice in recent times. In our study, we aim to determine its value in preoperative assessment of endometrial carcinoma. A retrospective study between January 2011 and March 2016 was conducted; we included all cases of carcinoma endometrium with a preoperative PET/CT scan. PET/CT images were analyzed and correlated with histological findings after surgical staging. A total of 46 cases were analyzed, mean age was 59.8 years, BMI 30.8 kg/m2, and most common histology endometrioid type (69.5%). We correlated PET/CT findings with histopathology as reference standard. PET/CT had a sensitivity of 40%, moderate specificity (75%) and accuracy (71.7%), good NPV (91.2%), but poor PPV (16.7%) for lymph node involvement. A total of 10 (21.7%) cases were detected to have distant metabolically active lesions on PET/CT, seven out of these were positive for malignancy. And 90% of them were either non-endometrioid type or grade two and higher. We found that SUV of primary tumor was significantly higher in patients with deep myometrial invasion (p = 0.018), and high-risk histological type of tumor (p = 0.022), though not statistically significant when lymph nodal involvement (p = 0.9), cervical involvement (p = 0.56), or histological grade (p = 0.84) were considered. Sensitivity and specificity of PET/CT in staging endometrial cancer is not high enough to reliably tailor lymphadenectomy. Although SUV of the primary tumor was significantly higher in patients with deep myometrial invasion and high-risk histological type, it’s usefulness in classifying patients into predefined risk groups seems to be limited. However, it is useful in detecting distant metastasis especially in high-grade and non-endometrioid type of tumors. Thus, implementation of PET/CT as a surrogate for surgical staging of endometrial cancer remains enigmatic and is open to further research.
Similar content being viewed by others
References
Balasubramaniam G, Sushama S, Rasika B, Mahantshetty U (2013) Hospital-based study of endometrial cancer survival in Mumbai, India. Asian Pac J Cancer Prev 14:977–980
WHO (2012) GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed date 3 Apr 2015
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR & Sessa C (2015) Ann Oncol 2015; 00: 1–26
SEER Cancer Statistics Factsheets: Endometrial cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/corp.html. Accessed Aug 2016
National Cancer Institute (2015) Endometrial cancer treatment Physician Data Query (PDQ). http://www.cancer.gov/cancertopics/pdq/treatment/endometrial/ healthprofessional. Accessed date 1 Apr 2015
ACOG (2005) ACOG practice bulletin, clinical management guidelines for obstetriciangynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 106:413–425
Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105:109
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) American Joint Committee on Cancer. American Joint Committee on Cancer Staging Manual, 7th edn. Springer, New York, pp 403–418
Epstein E, Blomqvist L (2014) Imaging in endometrial cancer. Best Pract Res Clin Obstet Gynaecol 28:721–739
Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716
Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373:125–136
Petersen H, Holdgaard PC, Madsen PH et al (2016) FDG PET/CT in cancer: comparison of actual use with literature-based recommendations. Eur J Nucl Med Mol Imaging 43:695–706. https://doi.org/10.1007/s00259-015-3217-0
Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen HB, Haldorsen IS (2016) High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. J Nucl Med 57:879–885
Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K (2009) Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol 19:1529–1536
Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, Qvist I, Hansen MR, Fisker R, Andersen ES, Sperling L, Nielsen AL, Asmussen J, Høgdall E, Fagö-Olsen CL, Christensen IJ, Nedergaard L, Jochumsen K, Høgdall C (2013) MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol 128(2):300–308. https://doi.org/10.1016/j.ygyno.2012.11.025
Wu WJ, Yu MS, Su HY, Lin KS, Lu KL, Hwang KS (2013) The accuracy of magnetic resonance imaging for preoperative deep myometrium assessment in endometrial cancer. Taiwan J Obstet Gynecol 52:210–214
Colombo N, Carinelli S, Colombo A, Marini C, Rollo D, Sessa C et al (2012) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii27–vii32
Peungjesada S, Bhosale PR, Balachandran A, Iyer RB (2009) Magnetic resonance imaging of endometrial carcinoma. J Comput Assist Tomogr 33:601–608
Murakami T, Kurachi H, Nakamura H, Tsuda K, Miyake A, Tomoda K, Hori S, Kozuka T (1995) Cervical invasion of endometrial carcinoma-evaluation by parasagittal MR imaging. Acta Radiol 36:248–253
Pelikan HM, Trum JW, Bakers FC, Beets-Tan RG, Smits LJ, Kruitwagen RF (2013) Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review. Cancer Imaging 13(3):314–322. https://doi.org/10.1102/1470-7330.2013.0032
Kadkhodayan S, Shahriari S, Treglia G, Yousefi Z, Sadeghi R (2013) Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature. Gynecol Oncol 128(2):397–404. https://doi.org/10.1016/j.ygyno.2012.10.022
Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C et al (2013) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi33–vi38
Dalla Palma M, Gregianin M, Fiduccia P, Evangelista L, Cervino AR, Saladini G et al (2012) PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis. Crit Rev Oncol Hematol 83(1):84–98. https://doi.org/10.1016/j.critrevonc.2011.10.002
Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH (2012) 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and metaanalysis. Eur J Radiol 81(11):3511–3517
Kim HJ, Cho A, Yun M, Kim YT, Kang WJ (2016) Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Ann Nucl Med 30:104–113. https://doi.org/10.1007/s12149-015-1037-8
Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS (2015) Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. J Nucl Med 56(8):1191–1198. https://doi.org/10.2967/jnumed.115.159913
Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R, Elisei F, Dolci C, Cuzzocrea M, Milani R, Messa C (2015) Staging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping. Clin Nucl Med 40(10):780–785. https://doi.org/10.1097/RLU.0000000000000852
Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, Elisei F, Montanelli L, Buda A, Messa C (2013) Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol 130(2):306–311. https://doi.org/10.1016/j.ygyno.2013.05.011
Yahata T, Yagi S, Mabuchi Y, Tanizaki Y, Kobayashi A, Yamamoto M, Mizoguchi M, Nanjo S, Shiro M, Ota N, Minami S, Terada M, Ino K (2016) Prognostic impact of primary tumor SUVmax on preoperative 18F-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography in endometrial cancer and uterine carcinosarcoma. Mol Clin Oncol 5:467–474. https://doi.org/10.3892/mco.2016.980
Antonsen SL, Loft A, Fisker R, Nielsen AL, Andersen ES, Høgdall E, Tabor A, Jochumsen K, Fagö-Olsen CL, Asmussen J, Berthelsen AK, Christensen IJ, Høgdall C (2013) SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. Gynecol Oncol 129(2):298–303. https://doi.org/10.1016/j.ygyno.2013.01.019.
Kitajima K, Suenaga Y, Ueno Y, Maeda T, Ebina Y, Yamada H, Okunaga T, Kubo K, Sofue K, Kanda T, Tamaki Y, Sugimura K (2015) Preoperative risk stratification using metabolic parameters of 18F FDG PET/CT in patients with endometrial cancer. Eur J Nucl Med Mol Imaging 42:1268–1275. https://doi.org/10.1007/s00259-015-3037-2
Lee HJ, Ahn BC, Hong CM, Song BI, Kim HW, Kang S, Jeong SY, Lee SW, Lee J (2011) Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer. Nuklearmedizin 50(5):204–213
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kulkarni, R., Bhat, R.A., Dhakharia, V. et al. Role of Positron Emission Tomography/Computed Tomography in Preoperative Assessment of Carcinoma Endometrium—a Retrospective Analysis. Indian J Surg Oncol 10, 225–231 (2019). https://doi.org/10.1007/s13193-018-0826-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-018-0826-7